Cross-neutralization effect of the third dose of inactivated COVID-19 vaccine against the SARS-CoV-2 variants
Background The ongoing emergence of SARS-CoV-2 variants has raised concerns about the breadth of the immune response provided by existing vaccines.Research design and methods In this study, participants aged 18-75 years with no prior COVID-19 infection or vaccination history were enrolled to receive...
Saved in:
| Main Authors: | Yuqing Li, Jiexiao He, Wenqing Liu, Runjie Qi, Jingxin Li, Fengcai Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Expert Review of Vaccines |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14760584.2025.2550984 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A 22 month prospective assessment of neutralizing and IgG antibody levels against SARS-CoV-2 variants following homologous and heterologous BNT162b2 boosting
by: Aini Syahida Mat Yassim, et al.
Published: (2025-07-01) -
Evaluation of humoral and cellular immune responses in healthcare workers with varying levels of SARS-CoV-2 exposure: effects of CoronaVac vaccination followed by heterologous booster
by: Shayane Martins Rodrigues Gomes, et al.
Published: (2025-05-01) -
Protection and waning of vaccine-induced, natural and hybrid immunity to SARS-CoV-2 in Hong Kong
by: Jialiang Jiang, et al.
Published: (2025-12-01) -
Immunogenicity and safety of CoronaVac vaccine in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up
by: Camila Amormino Corsini, et al.
Published: (2025-07-01) -
Incidence and Factors Associated with Self-Reported Skin Symptoms of Allergic Reactions to COVID-19 Vaccines
by: Karnsinee Thanborisutkul, et al.
Published: (2025-03-01)